The superbug that just came to the U.S. is still treatable with other antibiotics but they are worried that its resistance could spread to other strains of bacteria. We have been creating more and more resistant strains by needlessly taking antibiotics over the years. I believe that someday all bacteria will be resistant to all types of current antibiotics, but that just means we will have to discover a new type of cure.
Every day, scientists around the world are finding ways to cure and prevent a variety of different illnesses. Therefore, provided that science continues to get the funding it deserves, it will only be a matter of time before new and improved antibiotics are discovered, and any outbreak of a superbug can be contained and treated effectively.
Rather than innovate and find a new solution to antibiotic resistant bacteria, it is much more likely US healthcare providers and pharmaceutical companies will reapply antibiotics in and different iterations to slow the spread of disease. This will perpetuate the cycle of chasing diseases the evolve and allow the current system to remain in place. Profit does die rather hard.
The evolution of antibiotic resistant bacteria is nothing new. Diseases such as tuberculosis have become increasingly harder to control with the current suite of antibiotics. However, finding a germ that is resistant to all known antibiotics is of concern. Right now, the pan-resistant bacteria are fairly rare; however, that will not always be the case. A be taken to minimize the impact of both antibiotic resistant germs and to minimize the chances for other bacteria to evolve into resistant strains. First and foremost, antibiotics need to be used a more targeted fashion. One thing has led to the current problem is both the over prescription, coupled with the failure on the part of many patients to fully adhere to the antibiotic regimen. This creates an evolutionary hothouse for bacteria, exposing them to antibiotics without killing off all of them, leading to the development of resistant strains. Related to this si the unregulated use of antibiotics in many countries; this must come to an end, to prevent poor or inappropriate use. Second, the incidence of infection can be reduced by better hygiene - both personal and in such areas as food production and water treatment and distribution - and more rigorous isolation of the sick. The former will reduce the chances of initial infection, the latter the spread of diseases. Third, more Research & Development dollars going towards creating new treatment regimens. While not a 'silver bullet ' - in the sense that, as we have seen, bacteria can evolve into resistant strains - many of the antibiotics used are derived from work done decades ago. While R&D is an ongoing process, it needs to be prioritized on a global scale. The emergence of resistant strains is cause for concern; however, there are options. They just require time, money, and coordination on a global scale. While this may sound daunting, the alternative - going back the days when bacteria raged unchecked through the population - is not an option.